İçeriğe geç

Friends of the Global Fund, Japan (FGFJ)

@fgfj-en.bsky.social did:plc:i6xducw5qe3prtwqbpu5h5i6

Friends of the Global Fund, Japan (FGFJ) supports the Global Fund’s fight against #AIDS, #TB, and #Malaria through engaging and mobilizing Japanese stakeholders. Based in New York, USA & Tokyo, Japan https://fgfj-en.jcie.or.jp

Bluesky’a katılma tarihi:

Takipçi
77
Takip edilen
68
Post
112
Sıralamaya girdiği gün
0

Özet

Friends of the Global Fund, Japan (FGFJ) (@fgfj-en.bsky.social), 7 Şubat 2025 tarihinde katılan bir Bluesky kullanıcısı. 77 takipçisi var, 68 hesabı takip ediyor ve 112 post paylaştı.

Sıralama geçmişi

Bu hesabın postlarının Debya günlük listesine girdiği en iyi günler.

Bu hesap henüz günlük sıralamaya girmedi.

Son beğendiği postlar

Bluesky ağındaki herkese açık beğeniler.

  • Unitaid@unitaid.bsky.social

    Ending HIV requires integrated, people-centered care. We connect HIV services with care for coinfections and related health needs to strengthen health systems and improve access to continuous, comprehensive care. Learn more: https://unitaid.org/uploads/Unitaid-HIV-and-Coinfections.pdf

    Postu göster
  • Devex@devex.com

    The State Department's head of foreign assistance announced efforts to roll out lenacapavir will now aim to reach 3 million people over three years — up from a 2 million-person target announced last September.

    Postu göster
  • UNAIDS Global@unaids.org

    UNAIDS welcomes expanded rollout of HIV prevention medicine and calls for urgent action to ensure equitable and affordable global access Read full statement here: www.unaids.org/en/resources...

    Postu göster
  • Unitaid@unitaid.bsky.social

    Unitaid works to make the best HIV tools available faster and at lower cost. Dolutegravir changed treatment. Oral PrEP changed prevention. Now lenacapavir, a twice-yearly injection, could change what’s possible for millions at risk of HIV. Learn more: https://ow.ly/fGtX50YI5B2

    Postu göster
  • AVAC@avac.org

    Today, Global Fund, the State Dept and Gilead Sciences announced that they are increasing the 3-year target from 2 to 3 million people on #LEN. AVAC and Access Bridge are analyzing the announcement and will share further info soon! Meanwhile, check out the latest resources: avac.org/blog/resourc...

    Postu göster

Daha fazlası için üye girişi yap

Blokladığı hesaplar

Bluesky’da bloklar herkese açık kayıtlardır.

Bu hesap kimseyi bloklamıyor.